Time course for the induction and maintenance of tolerance to Δ9-tetrahydrocannabinol in mice

被引:75
作者
Bass, CE [1 ]
Martin, BR [1 ]
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
delta-9-tetrahydrocannabinol; Delta(9)-THC; cannabinoid; tolerance; time course;
D O I
10.1016/S0376-8716(99)00150-7
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The time course for the development of tolerance to delta-9-tetrahydrocannabinol (Delta(9)-THC) was studied in an effort to determine the role that length of dosing may have in the onset and maintenance of tolerance. Mice were chronically treated with either vehicle or 10 mg/kg of Delta(9)-THC subcutaneously twice a day. The mice were tested 24 h after the last injection for tolerance as assessed by the production of antinociception and suppression of spontaneous activity. Tolerance was first observed after three injections of Delta(9)-THC (1.5 days) resulting in a 7-fold and 23-fold decrease in potency for the measures of antinociception and hypoactivity, respectively. Seven injections of Delta(9)-THC (3.5 days of dosing) resulted in a 12-fold and 36-fold decrease in potency, respectively, while 13 injections of Delta(9)-THC (6.5 days of dosing) produced a 6.2-fold and 9.8-fold degree of tolerance. The time course for the recovery from Delta(9)-THC-induced tolerance was also determined with a separate group of animals. Mice were dosed for 6.5 days with 10 mg/kg of Delta(9)-THC and were not tested until 4.5, 7.5, and 11.5 days after cessation of drug treatment. After 4.5 days without drug treatment the mice exhibited a 7.5-fold and 2.3-fold degree of tolerance as measured by antinociception and hypoactivity, respectively. After 7.5 days without drug treatment a 3.4-fold degree of tolerance remained for the measure of antinociception, while no tolerance was detected for the measure of hypoactivity. No tolerance was observed for the measure of antinociception after 11.5 days without drug treatment. This time course indicates that the mechanisms responsible for either the production or maintenance of tolerance differ between the measures of antinociception and suppression of spontaneous activity. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 25 条
  • [1] DEVELOPMENT OF BEHAVIORAL TOLERANCE TO DELTA-9-THC WITHOUT ALTERATION OF CANNABINOID RECEPTOR-BINDING OR MESSENGER-RNA LEVELS IN WHOLE-BRAIN
    ABOOD, ME
    SAUSS, C
    FAN, F
    TILTON, CL
    MARTIN, BR
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 46 (03) : 575 - 579
  • [2] Bliss C.I., 1967, Statistics in Biology
  • [3] ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASES BY STIMULATION OF THE CENTRAL CANNABINOID RECEPTOR CB1
    BOUABOULA, M
    POINOTCHAZEL, C
    BOURRIE, B
    CANAT, X
    CALANDRA, B
    RINALDICARMONA, M
    LEFUR, G
    CASELLAS, P
    [J]. BIOCHEMICAL JOURNAL, 1995, 312 : 637 - 641
  • [4] TOLERANCE TO CHRONIC ADMINISTRATION OF CANNABIS SATIVA (MARIHUANA) IN RATS
    CARLINI, EA
    [J]. PHARMACOLOGY, 1968, 1 (02) : 135 - &
  • [5] Colquhoun D., 1971, LECT BIOSTATISTICS I
  • [6] DOWN-REGULATION OF RAT-BRAIN CANNABINOID BINDING-SITES AFTER CHRONIC DELTA-9-TETRAHYDROCANNABINOL TREATMENT
    DEFONSECA, FR
    GORRITI, MA
    FERNANDEZRUIZ, JJ
    PALOMO, T
    RAMOS, JA
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 47 (01) : 33 - 40
  • [7] ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR
    DEVANE, WA
    HANUS, L
    BREUER, A
    PERTWEE, RG
    STEVENSON, LA
    GRIFFIN, G
    GIBSON, D
    MANDELBAUM, A
    ETINGER, A
    MECHOULAM, R
    [J]. SCIENCE, 1992, 258 (5090) : 1946 - 1949
  • [8] DEWEY WL, 1970, J PHARMACOL EXP THER, V175, P435
  • [9] FAN F, 1994, J PHARMACOL EXP THER, V271, P1383
  • [10] Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice
    Fan, F
    Tao, Q
    Abood, M
    Martin, BR
    [J]. BRAIN RESEARCH, 1996, 706 (01) : 13 - 20